• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估机器学习算法在肾素-血管紧张素-醛固酮系统抑制剂相关肾脏不良事件预测中的应用。

Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction.

机构信息

Başkent University Faculty of Medicine, Department of Internal Medicine, Division of General Internal Medicine.

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of General Internal Medicine.

出版信息

Eur J Intern Med. 2023 Aug;114:74-83. doi: 10.1016/j.ejim.2023.05.021. Epub 2023 May 20.

DOI:10.1016/j.ejim.2023.05.021
PMID:37217407
Abstract

BACKGROUND

Renin-angiotensin-aldosterone system inhibitors (RAASi) are commonly used medications. Renal adverse events associated with RAASi are hyperkalemia and acute kidney injury. We aimed to evaluate the performance of machine learning (ML) algorithms in order to define event associated features and predict RAASi associated renal adverse events.

MATERIALS AND METHODS

Data of patients recruited from five internal medicine and cardiology outpatient clinics were evaluated retrospectively. Clinical, laboratory, and medication data were acquired via electronic medical records. Dataset balancing and feature selection for machine learning algorithms were performed. Random forest (RF), k-nearest neighbor (kNN), naïve Bayes (NB), extreme gradient boosting (xGB), support vector machine (SVM), neural network (NN), and logistic regression (LR) were used to create a prediction model.

RESULTS

409 patients were included, and 50 renal adverse events occurred. The most important features predicting the renal adverse events were the index K and glucose levels, as well as having uncontrolled diabetes mellitus. Thiazides reduced RAASi associated hyperkalemia. kNN, RF, xGB and NN algorithms have the highest and similar AUC (≥ 98%), recall (≥ 94%), specifity (≥ 97%), precision (≥ 92%), accuracy (≥ 96%) and F1 statistics (≥ 94%) performance metrics for prediction.

CONCLUSION

RAASi associated renal adverse events can be predicted prior to medication initiation by machine learning algorithms. Further prospective studies with large patient numbers are needed to create scoring systems as well as for their validation.

摘要

背景

肾素-血管紧张素-醛固酮系统抑制剂(RAASi)是常用的药物。与 RAASi 相关的肾脏不良事件包括高钾血症和急性肾损伤。我们旨在评估机器学习(ML)算法的性能,以便定义与事件相关的特征并预测 RAASi 相关的肾脏不良事件。

材料和方法

回顾性评估了从五个内科和心脏病学门诊招募的患者的数据。通过电子病历获取临床、实验室和药物数据。对机器学习算法进行数据集平衡和特征选择。使用随机森林(RF)、k-最近邻(kNN)、朴素贝叶斯(NB)、极端梯度提升(xGB)、支持向量机(SVM)、神经网络(NN)和逻辑回归(LR)创建预测模型。

结果

共纳入 409 例患者,发生 50 例肾脏不良事件。预测肾脏不良事件的最重要特征是指数 K 和血糖水平,以及患有未控制的糖尿病。噻嗪类药物可降低 RAASi 相关的高钾血症。kNN、RF、xGB 和 NN 算法在预测方面具有最高和相似的 AUC(≥98%)、召回率(≥94%)、特异性(≥97%)、精度(≥92%)、准确性(≥96%)和 F1 统计数据(≥94%)性能指标。

结论

通过机器学习算法,可以在开始用药之前预测 RAASi 相关的肾脏不良事件。需要进一步进行前瞻性研究,纳入大量患者,以创建评分系统并对其进行验证。

相似文献

1
Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction.评估机器学习算法在肾素-血管紧张素-醛固酮系统抑制剂相关肾脏不良事件预测中的应用。
Eur J Intern Med. 2023 Aug;114:74-83. doi: 10.1016/j.ejim.2023.05.021. Epub 2023 May 20.
2
Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia.机器学习模型预测高钾血症患者的心血管和肾脏结局及死亡率。
Nutrients. 2022 Nov 3;14(21):4614. doi: 10.3390/nu14214614.
3
Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.患有心血管代谢疾病的患者在使用肾素-血管紧张素-醛固酮系统抑制剂治疗时发生高钾血症的结局。
Am Heart J. 2023 Apr;258:49-59. doi: 10.1016/j.ahj.2023.01.002. Epub 2023 Jan 13.
4
Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom.在英国的一个新诊断的慢性肾脏病或心力衰竭患者队列中,观察到肾素-血管紧张素-醛固酮系统抑制剂剂量、高钾血症与不良临床结局之间的真实世界关联。
J Am Heart Assoc. 2019 Nov 19;8(22):e012655. doi: 10.1161/JAHA.119.012655. Epub 2019 Nov 12.
5
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes.由于高钾血症而停用肾素-血管紧张素-醛固酮系统抑制剂会导致更高的心肾结局。
Am J Nephrol. 2023;54(7-8):258-267. doi: 10.1159/000531102. Epub 2023 May 18.
6
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.高钾血症起始用钠锆石环硅酸酯治疗患者的肾素-血管紧张素-醛固酮系统抑制剂的真实世界调整:OPTIMIZE I 研究。
Adv Ther. 2023 Jun;40(6):2886-2901. doi: 10.1007/s12325-023-02518-w. Epub 2023 May 4.
7
Machine learning algorithms for predicting COVID-19 mortality in Ethiopia.用于预测埃塞俄比亚 COVID-19 死亡率的机器学习算法。
BMC Public Health. 2024 Jun 28;24(1):1728. doi: 10.1186/s12889-024-19196-0.
8
A machine learning approach to predicting vascular calcification risk of type 2 diabetes: A retrospective study.机器学习方法预测 2 型糖尿病血管钙化风险:一项回顾性研究。
Clin Cardiol. 2024 Apr;47(4):e24264. doi: 10.1002/clc.24264.
9
[Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].[高钾血症和肾素-血管紧张素-醛固酮系统抑制剂(RAASi)不依从性对心力衰竭或慢性肾脏病患者的影响]
G Ital Nefrol. 2019 Sep 24;36(5):2019-vol5.
10
Adverse effects during treatment with renin-angiotensin-aldosterone system inhibitors; should we stay or should we stop?肾素-血管紧张素-醛固酮系统抑制剂治疗期间的不良反应;我们该继续还是停药?
Curr Opin Nephrol Hypertens. 2023 May 1;32(3):290-296. doi: 10.1097/MNH.0000000000000878. Epub 2023 Feb 15.

引用本文的文献

1
When the whole is greater than the sum of its parts: why machine learning and conventional statistics are complementary for predicting future health outcomes.当整体大于部分之和:为何机器学习与传统统计学在预测未来健康结果方面相辅相成。
Clin Kidney J. 2025 Feb 20;18(4):sfaf059. doi: 10.1093/ckj/sfaf059. eCollection 2025 Apr.
2
Machine Learning Insights Into Uric Acid Elevation With Thiazide Therapy Commencement and Intensification.机器学习对噻嗪类药物治疗起始和强化过程中尿酸升高的见解。
Cureus. 2023 Dec 26;15(12):e51109. doi: 10.7759/cureus.51109. eCollection 2023 Dec.
3
Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors: comment.
关于接受肾素 - 血管紧张素 - 醛固酮系统抑制剂治疗的患者高钾血症管理的建议:评论
Intern Emerg Med. 2024 Apr;19(3):879-881. doi: 10.1007/s11739-023-03520-4. Epub 2024 Jan 3.